𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Toward dysfunctional connectivity: a review of neuroimaging findings in pediatric major depressive disorder

✍ Scribed by Leslie A. Hulvershorn; Kathryn Cullen; Amit Anand

Publisher
Springer-Verlag
Year
2011
Tongue
English
Weight
418 KB
Volume
5
Category
Article
ISSN
1931-7557

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Major depressive disorder in a family st
Major depressive disorder in a family study of obsessive–compulsive disorder with pediatric probands
✍ Gregory L. Hanna; Joseph A. Himle; Barbara S. Hanna; Katherine J. Gold; Brenda W πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 113 KB

## Objective: This study examined the comorbidity of obsessive-compulsive disorder (ocd) with major depressive disorder (mdd) in a family study of ocd with pediatric probands. ## Method: This study assessed the lifetime prevalence of mdd in 141 first-degree relatives (fdr) and 452 second-degree r

Patterns of comorbidity in panic disorde
Patterns of comorbidity in panic disorder and major depression: findings from a nonreferred sample
✍ Joseph Biederman; Carter Petty; Stephen V. Faraone; Dina R. Hirshfeld-Becker; Au πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 90 KB

Previous findings in referred adult samples document major depression as having important moderating effects on the patterns of comorbidity for panic disorder and major depression. This study evaluated whether these patterns of comorbidity are moderated by referral bias. Panic disorder (PD) and majo

A double-blind dose-finding study of rol
A double-blind dose-finding study of rolipram in patients with major depressive disorder
✍ E. H. Bennie; S. K. Chakravarti; C. M. B. Jarman; K. Khan; D. Master; G. H. Murr πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 460 KB πŸ‘ 2 views

Rolipram improves signal transmission in central noradrenergic neurones with a novel mechanism of action: enhanced noradrenaline (first messenger) synthesis and release, and inhibition of cAMP (second messenger) breakdown. Several comparative trials to prove antidepressant activity are under way. Re